Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Enantioselective uptake of fexofenadine by Caco-2 cells as model intestinal epithelial cells.

Togami K, Tosaki Y, Chono S, Morimoto K, Hayasaka M, Tada H.

J Pharm Pharmacol. 2013 Jan;65(1):22-9. doi: 10.1111/j.2042-7158.2012.01569.x. Epub 2012 Oct 25.

PMID:
23215684
2.

Vectorial transport of fexofenadine across Caco-2 cells: involvement of apical uptake and basolateral efflux transporters.

Ming X, Knight BM, Thakker DR.

Mol Pharm. 2011 Oct 3;8(5):1677-86. doi: 10.1021/mp200026v. Epub 2011 Aug 5.

PMID:
21780830
3.

Effects of one-time apple juice ingestion on the pharmacokinetics of fexofenadine enantiomers.

Akamine Y, Miura M, Komori H, Saito S, Kusuhara H, Tamai I, Ieiri I, Uno T, Yasui-Furukori N.

Eur J Clin Pharmacol. 2014 Sep;70(9):1087-95. doi: 10.1007/s00228-014-1705-y. Epub 2014 Jun 7.

PMID:
24903351
4.

Pharmacokinetics of fexofenadine enantiomers in healthy subjects.

Miura M, Uno T, Tateishi T, Suzuki T.

Chirality. 2007 Mar;19(3):223-7.

PMID:
17230498
5.

Transport characteristics of fexofenadine in the Caco-2 cell model.

Petri N, Tannergren C, Rungstad D, Lennernäs H.

Pharm Res. 2004 Aug;21(8):1398-404.

PMID:
15359574
6.

Fruit juices inhibit organic anion transporting polypeptide-mediated drug uptake to decrease the oral availability of fexofenadine.

Dresser GK, Bailey DG, Leake BF, Schwarz UI, Dawson PA, Freeman DJ, Kim RB.

Clin Pharmacol Ther. 2002 Jan;71(1):11-20.

PMID:
11823753
7.

Relative contribution of absorptive and secretory transporters to the intestinal absorption of fexofenadine in rats.

Ujie K, Oda M, Kobayashi M, Saitoh H.

Int J Pharm. 2008 Sep 1;361(1-2):7-11. doi: 10.1016/j.ijpharm.2008.05.004. Epub 2008 May 14.

PMID:
18572335
8.

Effect of coadministration of single and multiple doses of rifampicin on the pharmacokinetics of fexofenadine enantiomers in healthy subjects.

Kusuhara H, Miura M, Yasui-Furukori N, Yoshida K, Akamine Y, Yokochi M, Fukizawa S, Ikejiri K, Kanamitsu K, Uno T, Sugiyama Y.

Drug Metab Dispos. 2013 Jan;41(1):206-13. doi: 10.1124/dmd.112.048330. Epub 2012 Oct 31.

9.

Regional absorption of fexofenadine in rat intestine.

MacLean C, Moenning U, Reichel A, Fricker G.

Eur J Pharm Sci. 2010 Dec 23;41(5):670-4. doi: 10.1016/j.ejps.2010.09.007. Epub 2010 Sep 30.

PMID:
20869437
10.

Transporter-mediated intestinal absorption of fexofenadine in rats.

Kikuchi A, Nozawa T, Wakasawa T, Maeda T, Tamai I.

Drug Metab Pharmacokinet. 2006 Aug;21(4):308-14.

11.

Involvement of intestinal uptake transporters in the absorption of azithromycin and clarithromycin in the rat.

Garver E, Hugger ED, Shearn SP, Rao A, Dawson PA, Davis CB, Han C.

Drug Metab Dispos. 2008 Dec;36(12):2492-8. doi: 10.1124/dmd.108.022285. Epub 2008 Aug 28.

12.

Inhibition of oat3-mediated renal uptake as a mechanism for drug-drug interaction between fexofenadine and probenecid.

Tahara H, Kusuhara H, Maeda K, Koepsell H, Fuse E, Sugiyama Y.

Drug Metab Dispos. 2006 May;34(5):743-7. Epub 2006 Feb 2.

13.

Influence of drug-transporter polymorphisms on the pharmacokinetics of fexofenadine enantiomers.

Akamine Y, Miura M, Sunagawa S, Kagaya H, Yasui-Furukori N, Uno T.

Xenobiotica. 2010 Nov;40(11):782-9. doi: 10.3109/00498254.2010.515318.

PMID:
20839930
14.

OATP and P-glycoprotein transporters mediate the cellular uptake and excretion of fexofenadine.

Cvetkovic M, Leake B, Fromm MF, Wilkinson GR, Kim RB.

Drug Metab Dispos. 1999 Aug;27(8):866-71.

15.

Fruit juice inhibition of uptake transport: a new type of food-drug interaction.

Bailey DG.

Br J Clin Pharmacol. 2010 Nov;70(5):645-55. doi: 10.1111/j.1365-2125.2010.03722.x. Review.

16.

Pharmacokinetic drug interaction between fexofenadine and fluvastatin mediated by organic anion-transporting polypeptides in rats.

Qiang F, Lee BJ, Lee W, Han HK.

Eur J Pharm Sci. 2009 Jun 28;37(3-4):413-7. doi: 10.1016/j.ejps.2009.03.012. Epub 2009 Apr 1.

PMID:
19428223
17.

Effects of multiple-dose rifampicin 450 mg on the pharmacokinetics of fexofenadine enantiomers in Japanese volunteers.

Akamine Y, Miura M, Yasui-Furukori N, Ieiri I, Uno T.

J Clin Pharm Ther. 2015 Feb;40(1):98-103. doi: 10.1111/jcpt.12213. Epub 2014 Sep 27.

PMID:
25263393
18.

Intestinal drug transporter expression and the impact of grapefruit juice in humans.

Glaeser H, Bailey DG, Dresser GK, Gregor JC, Schwarz UI, McGrath JS, Jolicoeur E, Lee W, Leake BF, Tirona RG, Kim RB.

Clin Pharmacol Ther. 2007 Mar;81(3):362-70. Epub 2007 Jan 10.

PMID:
17215845
19.

Multiple transport mechanisms involved in the intestinal absorption and first-pass extraction of fexofenadine.

Tannergren C, Petri N, Knutson L, Hedeland M, Bondesson U, Lennernäs H.

Clin Pharmacol Ther. 2003 Nov;74(5):423-36.

PMID:
14586383
20.

Clinical pharmacokinetics of fexofenadine enantiomers.

Miura M, Uno T.

Expert Opin Drug Metab Toxicol. 2010 Jan;6(1):69-74. doi: 10.1517/17425250903382615. Review.

PMID:
19947891
Items per page

Supplemental Content

Write to the Help Desk